Myelofibrosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 114: Line 114:
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |Neoplastic
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |Neoplastic
| style="padding: 5px 5px; background: #F5F5F5;" |[[Lymphoma]] (common)<br>[[Metastases]] (breast, lung, colon, ovary, melanoma)<br>[[Hemangioma]]<br>[[Lymphangioma]]<br>[[Angiosarcoma]]
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Lymphoma]]  
*[[Metastases]] from primary malignancies such as:
:*Breast carcinoma
:*Lung carcinoma
:*Colon carcinoma
:*Ovarian carcinoma
:*Melanoma
:*[[Hemangioma]]
:*[[Lymphangioma]]
:*[[Angiosarcoma]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |Trauma
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |Trauma
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hematoma]]<br>[[Pseudocyst]]
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Hematoma]]
*[[Pseudocyst]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |Connective tissue disorders
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |Connective tissue disorders
| style="padding: 5px 5px; background: #F5F5F5;" |[[Systemic lupus erythematosus]] (SLE)<br>[[Rheumatoid arthritis]]
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Systemic lupus erythematosus (SLE)]]
*[[Rheumatoid arthritis]]
*[[Felty's syndrome]]
*[[Felty's syndrome]]
*[[Juvenile rheumatoid arthritis]] (JRA)
*[[Juvenile rheumatoid arthritis]]
*[[Still's disease]]<br>
*[[Still's disease]]
|}
|}



Revision as of 20:12, 14 November 2018

Myelofibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelofibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelofibrosis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelofibrosis differential diagnosis

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelofibrosis differential diagnosis

CDC on Myelofibrosis differential diagnosis

Myelofibrosis differential diagnosis in the news

Blogs on Myelofibrosis differential diagnosis

Directions to Hospitals Treating Myelofibrosis

Risk calculators and risk factors for Myelofibrosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2], Sujit Routray, M.D. [3]

Overview

Myelofibrosis must be differentiated from other diseases that cause diffuse bone sclerosis, splenomegaly, anemia, leukopenia, thrombocytopenia, leukocytosis, thrombocytosis, and extramedullary hematopoiesis such as sickle cell disease, hyperthyroidism, sclerosing bone dysplasia, osteoblastic metastases, Paget's disease, acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), polycythemia vera, myelodysplastic syndrome, chronic myelomonocytic leukemia, acute panmyelosis, acute megakaryoblastic leukemia, cirrhosis, infections, neoplastic and lipid storage disorders.[1][2][3][4][5][6][7]

Differentiating Myelofibrosis from other Diseases

Myelofibrosis must be differentiated from other diseases that cause diffuse bone sclerosis, anemia, leukopenia, thrombocytopenia, leukocytosis, or thrombocytosis. They are presented in the table below.[2][3][4][6][7]

Type of diseases Diseases
Hematological
Metabolic bone disorders
Congenital
Malignancy
Other

Myelofibrosis must also be differentiated from other diseases that cause splenomegaly and/or extramedullary hematopoiesis. They are presented in the table below.[1][5][6]

Type of diseases Diseases
Hematological causes Anemia

Neoplastic/proliferative/redistribution of hematopoesis

* = may cause massive splenomegaly

Hemodynamic
Infections Viral

Bacterial

Fungal

Parasitic disease

Storage/metabolic/infiltrative disorders
Neoplastic
Trauma
Connective tissue disorders

References

  1. 1.0 1.1 Splenomegaly. Dr Henry Knipe and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/Italic textarticles/splenomegaly. Accessed on March 11, 2016
  2. 2.0 2.1 Bae E, Park CJ, Cho YU, Seo EJ, Chi HS, Jang S, Lee KH, Lee JH, Lee JH, Suh JJ, Im HJ (December 2013). "Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis". Int J Lab Hematol. 35 (6): 629–36. doi:10.1111/ijlh.12101. PMID 23693053.
  3. 3.0 3.1 Tefferi A (September 2014). "Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management". Am. J. Hematol. 89 (9): 915–25. doi:10.1002/ajh.23703. PMID 25124313.
  4. 4.0 4.1 Tefferi A (February 2013). "Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management". Am. J. Hematol. 88 (2): 141–50. doi:10.1002/ajh.23384. PMID 23349007.
  5. 5.0 5.1 Aumann K, Frey AV, May AM, Hauschke D, Kreutz C, Marx JP, Timmer J, Werner M, Pahl HL (November 2013). "[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis]". Pathologe (in German). 34 Suppl 2: 201–9. doi:10.1007/s00292-013-1824-8. PMID 24196613.
  6. 6.0 6.1 6.2 Differential diagnosis of myelofibrosis. Dr Henry Knipe and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 10, 2016
  7. 7.0 7.1 Diffuse bony sclerosis: differential diagnosis. Dr Craig Hacking and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/diffuse-bony-sclerosis-differential-diagnosis. Accessed on March 10, 2016

Template:WH Template:WS